Lie Ming Ding
Chief Executive Officer bei BETTA PHARMACEUTICALS CO., LTD.
Vermögen: 60 Mio $ am 31.03.2024
Profil
Der Gründer von Betta Pharmaceuticals Co., Ltd., Lie Ming Ding, ist derzeit Chairman, Co-Chief Executive Officer & GM bei Betta Pharmaceuticals Co., Ltd. und General Manager & Executive Director bei Ningbo Kaiming Venture Technology Co., Ltd. sowie Chairman & General Manager bei Zhejiang Betta Pharmaceuticals Co., Ltd. (eine Tochtergesellschaft von Ningbo Kaiming Venture Technology Co., Ltd.). Dr. Ding ist auch im Vorstand von Betta Investment (Hong Kong) Ltd. In der Vergangenheit war er Senior Research Associate-Cancer Institute an der University of Arkansas. Lie Ming Ding promovierte an der University of Arkansas.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.09.2023 | 9 924 563 ( 2,40% ) | 56 Mio $ | 31.03.2024 | |
| 30.09.2023 | 739 978 ( 56,97% ) | 4 Mio $ | 31.03.2024 |
Aktive Positionen von Lie Ming Ding
| Unternehmen | Position | Beginn |
|---|---|---|
| BETTA PHARMACEUTICALS CO., LTD. | Chief Executive Officer | 23.08.2013 |
Betta Investment (Hong Kong) Ltd.
 Betta Investment (Hong Kong) Ltd. Financial ConglomeratesFinance Betta Investment (Hong Kong) Ltd. engages in investment and trading. It invests in pharmaceutical research and development activities. The company was founded on October 14, 2014 and is headquartered in Hong Kong. | Director/Board Member | - |
Zhejiang Betta Pharmaceuticals Co., Ltd.
 Zhejiang Betta Pharmaceuticals Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Zhejiang Betta Pharmaceuticals Co., Ltd. engages in the research and development of anti-cancer drugs. The company was founded on November 22, 2013 and is headquartered in Hangzhou, China. | Chief Executive Officer | - |
Ningbo Kaiming Venture Technology Co., Ltd.
 Ningbo Kaiming Venture Technology Co., Ltd. Packaged SoftwareTechnology Services Ningbo Kaiming Venture Technology Co., Ltd. engages in software development. The company was founded on June 4, 2020 and is headquartered in Ningbo, China. | Chief Executive Officer | - |
Wuhan Healthgen Biotechnology Corp.
 Wuhan Healthgen Biotechnology Corp. BiotechnologyHealth Technology Wuhan Healthgen Biotechnology Corp. engages in the research and development in molecular pharmaceutical. Its products include recombinant human serum albumin, recombinant growth products, and proteins for cosmetics ingredients. The company was founded by Dai Chang Yang, Cai Yuan Bai, and Zhong Qiang Yuan on November 16, 2006 and is headquartered in Wuhan, China. | Director/Board Member | 20.06.2022 |
Ehemalige bekannte Positionen von Lie Ming Ding
| Unternehmen | Position | Ende |
|---|---|---|
| The University of Arkansas | Corporate Officer/Principal | - |
Ausbildung von Lie Ming Ding
| The University of Arkansas | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BETTA PHARMACEUTICALS CO., LTD. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Wuhan Healthgen Biotechnology Corp.
Wuhan Healthgen Biotechnology Corp. BiotechnologyHealth Technology Wuhan Healthgen Biotechnology Corp. engages in the research and development in molecular pharmaceutical. Its products include recombinant human serum albumin, recombinant growth products, and proteins for cosmetics ingredients. The company was founded by Dai Chang Yang, Cai Yuan Bai, and Zhong Qiang Yuan on November 16, 2006 and is headquartered in Wuhan, China. | Health Technology |
Betta Investment (Hong Kong) Ltd.
Betta Investment (Hong Kong) Ltd. Financial ConglomeratesFinance Betta Investment (Hong Kong) Ltd. engages in investment and trading. It invests in pharmaceutical research and development activities. The company was founded on October 14, 2014 and is headquartered in Hong Kong. | Finance |
Zhejiang Betta Pharmaceuticals Co., Ltd.
Zhejiang Betta Pharmaceuticals Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Zhejiang Betta Pharmaceuticals Co., Ltd. engages in the research and development of anti-cancer drugs. The company was founded on November 22, 2013 and is headquartered in Hangzhou, China. | Commercial Services |
Ningbo Kaiming Venture Technology Co., Ltd.
Ningbo Kaiming Venture Technology Co., Ltd. Packaged SoftwareTechnology Services Ningbo Kaiming Venture Technology Co., Ltd. engages in software development. The company was founded on June 4, 2020 and is headquartered in Ningbo, China. | Technology Services |
